Pfizer Makes Big News With Small Step In Opioid Class
This article was originally published in RPM Report
Executive Summary
Congress is moving towards a comprehensive opioid abuse law, while the White House is taking administrative steps to expand treatment for addiction. Pfizer’s agreement on best practices for marketing opioids with the city of Chicago looks like a small step by comparison – but it has big implications.